- Home
- AIN vs APLS Comparison
AIN vs APLS Comparison
Compare AIN & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIN
- APLS
- Stock Information
- Founded
- AIN 1895
- APLS 2009
- Country
- AIN United States
- APLS United States
- Employees
- AIN N/A
- APLS N/A
- Industry
- AIN Textiles
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- AIN Consumer Discretionary
- APLS Health Care
- Exchange
- AIN Nasdaq
- APLS Nasdaq
- Market Cap
- AIN 1.9B
- APLS 2.2B
- IPO Year
- AIN 1987
- APLS 2017
- Fundamental
- Price
- AIN $65.41
- APLS $18.56
- Analyst Decision
- AIN Buy
- APLS Buy
- Analyst Count
- AIN 5
- APLS 19
- Target Price
- AIN $81.00
- APLS $37.50
- AVG Volume (30 Days)
- AIN 239.7K
- APLS 2.9M
- Earning Date
- AIN 04-30-2025
- APLS 05-07-2025
- Dividend Yield
- AIN 1.64%
- APLS N/A
- EPS Growth
- AIN N/A
- APLS N/A
- EPS
- AIN 2.49
- APLS N/A
- Revenue
- AIN $1,206,059,000.00
- APLS $775,839,000.00
- Revenue This Year
- AIN $0.11
- APLS $1.54
- Revenue Next Year
- AIN $4.46
- APLS $22.80
- P/E Ratio
- AIN $26.52
- APLS N/A
- Revenue Growth
- AIN 1.17
- APLS 48.04
- 52 Week Low
- AIN $57.71
- APLS $16.10
- 52 Week High
- AIN $95.47
- APLS $43.76
- Technical
- Relative Strength Index (RSI)
- AIN 44.37
- APLS 51.97
- Support Level
- AIN $65.73
- APLS $16.61
- Resistance Level
- AIN $67.60
- APLS $17.48
- Average True Range (ATR)
- AIN 1.42
- APLS 0.90
- MACD
- AIN -0.13
- APLS 0.17
- Stochastic Oscillator
- AIN 7.79
- APLS 78.90
About AIN Albany International Corporation
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.